Listed Companies in Lianyungang Accelerate High Quality Growth

From: Lianyungang Updated: 2021-01-14 09:36

At the beginning of the New Year, the 21st century economic report released the latest China's top 500 listed companies. Hengrui Medicine and Hansoh Pharmaceutical are in the list, among which Hengrui Medicine ranks 23rd with a market value of 594.3 billion yuan, and Hansoh Pharmaceutical ranks 113th with a market value of 187.3 billion yuan. Zhou Mengling, Chief of the Scientific and Technological Achievements and Regional Innovation Section of the Municipal Science and Technology Bureau, said that the reason why listed companies in Lianyungang have such a high market value is that the capital market values the achievements of these enterprises in breaking through key technologies. Nowadays, more and more listed companies in Lianyungang regard scientific and technological innovation as the first strategy of enterprise development, and activate the vitality of enterprise development through sustainable R&D investment.

In recent years, local enterprises have coordinated with each other to promote the improvement of weaknesses and forging strengths, implemented key technology research projects in view of the vulnerable links of the industry, worked hard to solve a number of "bottle-neck" problems, and strived to create industrial advantages to produce more unique skills. Listed companies are the vanguard of the city to promote the key technology research. Hengrui Medicine, Hansoh Pharmaceutical, Solareast and other enterprises constantly create industry innovation records through scientific and technological innovation.

The growth model of Lianyungang is R&D-driven. "In the third quarter of last year, Hengrui's R&D expenditure rate in a single quarter exceeded 20% for the first time, and R&D investment continued to be strengthened. In addition to the clinical development of new drugs in the market, there are more than 30 new drugs in the clinical stage at present, about 10 new drugs are in the stage of registered research and will be NDA or listed in the next two or three years.”Analysts of GF Securities said frankly that behind Hengrui's high market value is the support of very strong innovation factors. In fact, looking at the listed companies in Lianyungang, we can see many industry benchmark innovation projects: Hengrui's PD-1 monoclonal antibody combined with chemotherapy can effectively prolong the life of patients with non-small cell lung cancer. Hausoh's flumatinib mesylate is the first independent innovation drug of CML in China. Micoe, a subsidiary of Solareast, has built a number of large-scale solar heating projects in Tibet for the first time, so that people in alpine regions like Qinghai and Tibet can live a clean and warm life. This achievement was also used as a case of China to share experience at the UN climate conference. Through scientific and technological innovation, these local enterprises not only solved the key technical problems of the industry, but also effectively supported the development of enterprises.

Building an innovation system is a good way to lead sustainable growth. In order to maintain the vigorous vitality of innovation, the listed enterprises in Lianyungang have constructed an innovation system in line with the world standards. The pharmaceutical industry alone has an R&D team of more than 5000 people, including more than 3000 people with master's degree or above, and a group of professional teams from overseas. At the same time, a number of small giant enterprises have continuously improved their market competitiveness through deep market segmentation and technological innovation. In addition, the municipal development and reform, industry and information technology, science and technology and other departments have also issued a series of incentive policies, with the help of the National Laboratory, engineering center, technology center and other platforms, continuously gathering scientific and technological resources, so as to make the scientific and technological innovation of listed companies in Lianyungang more sustainable.